"We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer," ...

Pembrolizumab (Keytruda), an anti-PD-1 antibody, cleared minimal residual disease and protected against recurrence in patients with DNA mismatch repair-deficient (dMMR) early-stage solid cancers who ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

A young woman is expressing her gratitude for a lifesaving clinical trial, while doctors hold their breath over the potential for federal funding cuts. After years of surgery, chemotherapy and ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

Participants in the trial were all patients with tumors ranging from stage 1 to stage 3, meaning the tumors had not yet spread, the release indicated.

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. While scientists believe that gut microbiota play an ...

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy, today announced new clinical and translational data from the ongoing ...

This innovative approach challenges the standard treatment path for many cancer patients, which typically includes surgery followed by chemotherapy and radiation. For patients facing difficult ...

Bianca Harvey lived a healthy and athletic lifestyle and was shocked to be diagnosed with colon cancer at 33. Now, she vows ...